Found: 24
Select item for more details and to access through your institution.
Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES).
- Published in:
- 2019
- By:
- Publication type:
- Letter
Factors associated with psychological distress in caregivers of patients with malignant gliomas.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 7, p. 5811, doi. 10.1007/s00520-022-06989-5
- By:
- Publication type:
- Article
Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregivers.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 5, p. 490, doi. 10.1093/nop/npaa021
- By:
- Publication type:
- Article
Survivorship care planning in neuro-oncology.
- Published in:
- Neuro-Oncology Practice, 2018, v. 5, n. 1, p. 3, doi. 10.1093/nop/npx034
- By:
- Publication type:
- Article
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29052-7
- By:
- Publication type:
- Article
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25859-y
- By:
- Publication type:
- Article
Palliative Care in Neuro-oncology: an Update.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 11, p. 645, doi. 10.1007/s11910-023-01301-2
- By:
- Publication type:
- Article
RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi234, doi. 10.1093/neuonc/noy148.971
- By:
- Publication type:
- Article
QOLP-23. PALLIATIVE CARE AND END OF LIFE HEALTHCARE UTILIZATION IN PATIENTS WITH INCURABLE PRIMARY MALIGNANT BRAIN TUMORS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi219, doi. 10.1093/neuonc/noy148.909
- By:
- Publication type:
- Article
QOLP-21. THE RELATIONSHIP BETWEEN CAREGIVING BURDEN AND ANXIETY SYMPTOMS IN CAREGIVERS OF PATIENTS WITH MALIGNANT GLIOMAS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi219, doi. 10.1093/neuonc/noy148.907
- By:
- Publication type:
- Article
NIMG-68. MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi191, doi. 10.1093/neuonc/noy148.792
- By:
- Publication type:
- Article
Hospice utilization in patients with malignant gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 538, doi. 10.1093/neuonc/nox196
- By:
- Publication type:
- Article
A practical guide to neuro-oncology fellowship.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 1, p. 73, doi. 10.1007/s11060-021-03897-2
- By:
- Publication type:
- Article
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 515, doi. 10.1007/s11060-021-03719-5
- By:
- Publication type:
- Article
Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 919, doi. 10.1002/onco.13835
- By:
- Publication type:
- Article
Intracranial Foreign Body Granuloma Mimicking Brain Tumor Recurrence: A Case Series.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e893, doi. 10.1002/onco.13766
- By:
- Publication type:
- Article
Low-Grade Gliomas.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 403, doi. 10.1634/theoncologist.2013-0345
- By:
- Publication type:
- Article
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 12, p. 2239, doi. 10.1093/neuonc/noad118
- By:
- Publication type:
- Article
Palliative care and end-of-life care in adults with malignant brain tumors.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 3, p. 447, doi. 10.1093/neuonc/noac216
- By:
- Publication type:
- Article
Corrigendum to: Palliative care and end-of-life care in adults with malignant brain tumors.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2180, doi. 10.1093/neuonc/noac126
- By:
- Publication type:
- Article
Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system malignancies.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 964, doi. 10.1093/neuonc/noab240
- By:
- Publication type:
- Article
Characterizing Distress and Identifying Modifiable Intervention Targets for Family Caregivers of Patients with Malignant Gliomas.
- Published in:
- Journal of Palliative Medicine, 2023, v. 26, n. 1, p. 17, doi. 10.1089/jpm.2021.0534
- By:
- Publication type:
- Article
Prognostic Awareness in Caregivers of Patients with Incurable Cancer.
- Published in:
- Journal of Palliative Medicine, 2021, v. 24, n. 4, p. 561, doi. 10.1089/jpm.2020.0236
- By:
- Publication type:
- Article